Rockwell Medical, Inc.
RMTI
$7.96
-$0.11-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.98% | -189.71% | 68.40% | -17.49% | 1.52% |
| Total Depreciation and Amortization | -3.72% | -6.41% | 0.37% | -3.37% | 4.45% |
| Total Amortization of Deferred Charges | 2.27% | -1.12% | 0.00% | 1.14% | 0.00% |
| Total Other Non-Cash Items | -32.22% | 34.66% | -14.40% | 1.79% | -21.51% |
| Change in Net Operating Assets | 1,032.86% | -114.68% | 230.45% | -161.25% | 147.91% |
| Cash from Operations | 1,345.51% | -107.29% | 275.29% | -170.88% | 152.88% |
| Capital Expenditure | -45.18% | -394.19% | 62.45% | -39.63% | -160.32% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.56% | 103.16% | 0.86% | -6,788.52% | -1.61% |
| Cash from Investing | -299.18% | 97.05% | 4.13% | -4,083.50% | -10,200.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 41.53% | -1.29% | 4.04% | -49.77% | 38.04% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 33.33% | 0.00% | -72.41% | 0.23% |
| Cash from Financing | 15.99% | 23.23% | -115.70% | 1,137.54% | 16.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 182.58% | 61.99% | -357.00% | 3.39% | 125.54% |